Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study-Reference-Cited by-同舟云学术

Lopinavir–ritonavir super-boosting in young HIV-infected children on rifampicin-based tuberculosis therapy compared with lopinavir–ritonavir without rifampicin: a pharmacokinetic modelling and clinical study

Published:2019-01 Issue:1 Volume:6 Page:e32-e42
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Rabie Helena,Denti Paolo,Lee Janice,Masango Mhleli,Coovadia Ashraf,Pillay Sandy,Liberty Afaaf,Simon François,McIlleron Helen,Cotton Mark F,Lallemant Marc

Funder

Wellcome Trust

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference30 articles.

1. Global tuberculosis report 2017,2017

2. Incidence and prevalence of opportunistic and other infections and the impact of antiretroviral therapy among HIV-infected children in low- and middle-income countries: a systematic review and meta-analysis;B-Lajoie;Clin Infect Dis,2016

3. Guidance for national tuberculosis and HIV programmes on the management of tuberculosis in HIV-infected children: recommendations for a public health approach,2010

4. Antiretroviral treatment for children with peripartum nevirapine exposure;Palumbo;N Engl J Med,2010

5. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children;Violari;N Engl J Med,2012

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-associated tuberculosis in infants, children, and adolescents younger than 15 years: an update on the epidemiology, diagnosis, prevention, and treatment;Current Opinion in HIV and AIDS;2024-07-31

2. THERAPEUTIC STRATEGIES AND USE OF LOPINAVIR/RITONAVIR IN PATIENTS WITH HIGHLY RESISTANT HUMAN IMMUNODEFICIENCY VIRUS;FARMACIA;2024

3. Population Pharmacokinetics of Pediatric Lopinavir/Ritonavir Oral Pellets in Children Living with HIV in Africa;Clinical Pharmacology & Therapeutics;2024-01-21

4. Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis;PLOS Medicine;2023-11-21

5. Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial;Clinical Infectious Diseases;2023-10-26